Anavex Life Sciences Corp AVXL:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 1:13 PM EDT
11.25quote price arrow down-0.36 (-3.10%)
Volume
422,814
52 week range
3.01 - 28.70

...

Loading . . .
  • Open11.52
  • Day High11.83
  • Day Low11.16
  • Prev Close11.61
  • 52 Week High28.70
  • 52 Week High Date02/04/21
  • 52 Week Low3.01
  • 52 Week Low Date04/21/20

Key Stats

  • Market Cap787.84M
  • Shares Out70.03M
  • 10 Day Average Volume1.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.56
  • YTD % Change110.05

KEY STATS

  • Open11.52
  • Day High11.83
  • Day Low11.16
  • Prev Close11.61
  • 52 Week High28.70
  • 52 Week High Date02/04/21
  • 52 Week Low3.01
  • 52 Week Low Date04/21/20
  • Market Cap787.84M
  • Shares Out70.03M
  • 10 Day Average Volume1.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.56
  • YTD % Change110.05

RATIOS/PROFITABILITY

  • EPS (TTM)-0.45
  • P/E (TTM)-24.76
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-32.784M
  • ROE (MRQ)-76.23%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Anavex Life Sciences Corp

There is no recent news for this security.

Profile

MORE
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to treat Alzheimer's disease (AD), other central nervous system (CNS) diseases, pain and various types of cancer. Its research and development pipeline includes a clinical drug candidate and various compounds in different stages of...
Christopher Missling Ph.D.
President
Sandra Boenisch
Chief Financial Officer
Address
51 W 52nd St Fl 7th
New York, NY
10019-6163
United States

Top Peers

SYMBOLLASTCHG%CHG
TCRR
TCR2 Therapeutics Inc
22.99-0.19-0.84%
ORIC
Oric Pharmaceuticals Inc
21.13+0.08+0.38%
HGEN
Humanigen Inc
13.60-0.29-2.09%
AKTX
Akari Therapeutics PLC
2.44+0.01+0.41%
BTAI
BioXcel Therapeutics Inc
33.58+0.42+1.25%